{"identifier":"36f2ced1-1b73-4253-88af-aacd7110215f","data":{"title":"Medicare Part D Prescribers - by Geography and Drug Data Dictionary","fields":[{"name":"Prscrbr_Geo_Lvl","label":"Geography Level","description":"Identifies the level of geography that the data in the row has been aggregated. A value of \u0027State\u0027 indicates the data in the row is aggregated to a single state identified in the Referring Provider State column for a given HCPCS Code Level. A value of \u0027National\u0027 indicates the data in the row is aggregated across all states for a given HCPCS Code Level."},{"name":"Prscrbr_Geo_Cd","label":"Prescriber Geography  Code","description":"FIPS code of the referring provider state. This variable is blank when reported at the national level."},{"name":"Prscrbr_Geo_Desc","label":"Prescriber Geography Description","description":"The state name where the provider is located, as reported in NPPES. The values include the 50 United States, District of Columbia, U.S. territories, Armed Forces areas, Unknown and Foreign Country. Data aggregated at the National level are identified by the word \u0027National\u0027."},{"name":"Brnd_Name","label":"Brand Name","description":"The trademarked name of the drug filled.","comment":"Brand Name is derived by linking the National Drug Codes (NDCs) from PDEs to a drug information database."},{"name":"Gnrc_Name","label":"Generic Name","description":"A term referring to the chemical ingredient of a drug rather than the trademarked brand name under which the drug is sold.","comment":"Generic Name is derived by linking the National Drug Codes (NDCs) from PDEs to a drug information database."},{"name":"Tot_Prscrbrs","label":"Total Prescribers","description":"Number of unique prescribers of Medicare Part D claims."},{"name":"Tot_Clms","label":"Total Claims","description":"The number of Medicare Part D claims. This includes original prescriptions and refills. Aggregated records based on Tot_Clms fewer than 11 are not included in the data file."},{"name":"Tot_30day_Fills","label":"Total 30 Day Fills","description":"Number of Standardized 30-Day Fills, Including Refills."},{"name":"Tot_Drug_Cst","label":"Total Drug Cost","description":"The aggregate drug cost paid for all associated claims. This amount includes ingredient cost, dispensing fee, sales tax, and any applicable vaccine administration fees and is based on the amounts paid by the Part D plan, Medicare beneficiary, government subsidies, and any other third-party payers."},{"name":"Tot_Benes","label":"Total Beneficiaries","description":"The total number of unique Medicare Part D beneficiaries with at least one claim for the drug. Counts fewer than 11 are suppressed and are indicated by a blank."},{"name":"GE65_Sprsn_Flag","label":"GE65 Supress Flag","description":"A flag that indicates the reason the GE65_Tot_Clms, GE65_Tot_30day_Fills, GE65_Tot_Drug_Cst and GE65_Tot_Day_Suply variables are suppressed."},{"name":"GE65_Tot_Clms","label":"GE65 Total Claims","description":"The number of Medicare Part D claims for beneficiaries age 65 and older. This includes original prescriptions and refills. A blank indicates the value is suppressed. See GE65_Bene_Sprsn_Flag regarding suppression of data."},{"name":"GE65_Tot_30day_Fills","label":"GE65 Total 30 Day Fills","description":"The number of Medicare Part D standardized 30-day fills for beneficiaries age 65 and older.The standardized 30-day fill is derived from the number of days supplied on each Part D claim divided by 30. Standardized 30-day fill values less than 1.0 were bottom-coded with a value of 1.0 and standardized 30-day fill values greater than 12.0 were top-coded with a value of 12.0. If GE65_Tot_Clms is suppressed, this variable is suppressed. A blank indicates the value is suppressed. GE65_Bene_Sprsn_Flag regarding suppression of data."},{"name":"GE65_Tot_Drug_Cst","label":"GE65 Total Drug Cost","description":"The aggregate total drug cost paid for all associated claims for beneficiaries age 65 and older. This amount includes ingredient cost, dispensing fee, sales tax, and any applicable vaccine administration fees and is based on the amounts paid by the Part D plan, Medicare beneficiary, government subsidies, and any other third-party payers. If GE65_Tot_Clms is suppressed, this variable is suppressed. A blank indicates the value is suppressed. See GE65_Bene_Sprsn_Flag regarding suppression of data."},{"name":"GE65_Bene_Sprsn_Flag","label":"GE65 Beneficary Supress Flag","description":"A flag indicating the reason the GE65_Tot_Benes variable is suppressed."},{"name":"GE65_Tot_Benes","label":"GE65 Total Beneficaries","description":"The total number of unique Medicare Part D beneficiaries age 65 and older with at least one claim for the drug. A blank indicates the value is suppressed. See GE65_Bene_Sprsn_Flag regarding suppression of data."},{"name":"LIS_Bene_Cst_Shr","label":"LIS Beneficary Cost Share","description":"The aggregate total cost that beneficiaries using a drug, with a low-income subsidy, paid during the year."},{"name":"NonLIS_Bene_Cst_Shr","label":"Non-LIS Beneficary Cost Share","description":"The aggregate total cost that beneficiaries using a drug, with no low-income subsidy, paid during the year."},{"name":"Opioid_Drug_Flag","label":"Opioid Drug Flag","description":"A flag indicating whether drugs in this Drug Name\/ Generic Name combination are identified as an opioid drug. The list for opioids are based upon drugs included in the Medicare Part D Overutilization Monitoring System (OMS). The list originates from the Centers for Disease Control and Prevention. Please visit the Medicare Part D OMS site for additional information.","comment":"The list for each of the drug categories (i.e., opioids, long-acting opioids, antibiotics and antipsychotics) used to construct the drug name (brand in the case of trademarked drugs) and generic name is internally comprised of National Drug Codes (NDCs), which serve as a universal product identifier for drugs. NDC identifiers can be further classified at the drug name and generic name, as is the case in the Part D Prescriber PUF detail data. However, it is possible for the same drug name and generic name to include NDC identifiers from the list as well as NDC identifiers that are not included in the list. For example, the drug name \u0027ERYTHROMYCIN\u0027 with generic name \u0027ERYTHROMYCIN BASE\u0027 includes ointment, gel, tablet, and capsule forms of the drug. However, only the tablet and capsule forms of the drug are included in the list for antibiotics and, as a result, are reflected in the beneficiary counts, total claim counts, and total costs for antibiotics."},{"name":"Opioid_LA_Drug_Flag","label":"Long Acting Opioid Drug Flag","description":"A flag indicating whether drugs in this Drug Name\/ Generic Name combination are identified as an long-acting opioid drug. The list for long-acting opioids are based upon drugs included in the Medicare Part D Overutilization Monitoring System (OMS). Those drugs were then identified by the National Center for Injury Prevention and Control. CDC compilation of benzodiazepines, muscle relaxants, stimulants, zolpidem, and opioid analgesics with oral morphine milligram equivalent conversion factors, 2018 version.","comment":"The list for each of the drug categories (i.e., opioids, long-acting opioids, antibiotics and antipsychotics) used to construct the drug name (brand in the case of trademarked drugs) and generic name is internally comprised of National Drug Codes (NDCs), which serve as a universal product identifier for drugs. NDC identifiers can be further classified at the drug name and generic name, as is the case in the Part D Prescriber PUF detail data. However, it is possible for the same drug name and generic name to include NDC identifiers from the list as well as NDC identifiers that are not included in the list. For example, the drug name \u0027ERYTHROMYCIN\u0027 with generic name \u0027ERYTHROMYCIN BASE\u0027 includes ointment, gel, tablet, and capsule forms of the drug. However, only the tablet and capsule forms of the drug are included in the list for antibiotics and, as a result, are reflected in the beneficiary counts, total claim counts, and total costs for antibiotics."},{"name":"Antbtc_Drug_Flag","label":"Antibiotic Drug Flag","description":"A flag indicating whether drugs in this Drug Name\/ Generic Name combination are identified as an antibiotic drug. The list for antibiotics was created by identifying antibiotic subcategories with the exclusion of the following types of products: tuberculosis agents, antimalarials, topical agents (topical ophthalmic, optic, vaginal, and dermatological agents, etc.).","comment":"The list for each of the drug categories (i.e., opioids, long-acting opioids, antibiotics and antipsychotics) used to construct the drug name (brand in the case of trademarked drugs) and generic name is internally comprised of National Drug Codes (NDCs), which serve as a universal product identifier for drugs. NDC identifiers can be further classified at the drug name and generic name, as is the case in the Part D Prescriber PUF detail data. However, it is possible for the same drug name and generic name to include NDC identifiers from the list as well as NDC identifiers that are not included in the list. For example, the drug name \u0027ERYTHROMYCIN\u0027 with generic name \u0027ERYTHROMYCIN BASE\u0027 includes ointment, gel, tablet, and capsule forms of the drug. However, only the tablet and capsule forms of the drug are included in the list for antibiotics and, as a result, are reflected in the beneficiary counts, total claim counts, and total costs for antibiotics."},{"name":"Antpsyct_Drug_Flag","label":"Antipsychotic Drug Flag","description":"A flag indicating whether drugs in this Drug Name\/ Generic Name combination are identified as an antipsychotic drug. The list for antipsychotics was created by identifying antipsychotic subcategories, including first and second generation antipsychotics, as well as antipsychotics included in combination with other drugs, (e.g., OLANZAPINE\/FLUOXETINE HCL).","comment":"The list for each of the drug categories (i.e., opioids, long-acting opioids, antibiotics and antipsychotics) used to construct the drug name (brand in the case of trademarked drugs) and generic name is internally comprised of National Drug Codes (NDCs), which serve as a universal product identifier for drugs. NDC identifiers can be further classified at the drug name and generic name, as is the case in the Part D Prescriber PUF detail data. However, it is possible for the same drug name and generic name to include NDC identifiers from the list as well as NDC identifiers that are not included in the list. For example, the drug name \u0027ERYTHROMYCIN\u0027 with generic name \u0027ERYTHROMYCIN BASE\u0027 includes ointment, gel, tablet, and capsule forms of the drug. However, only the tablet and capsule forms of the drug are included in the list for antibiotics and, as a result, are reflected in the beneficiary counts, total claim counts, and total costs for antibiotics."}]}}